These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11904356)

  • 1. Strontium overload and toxicity: impact on renal osteodystrophy.
    Cohen-Solal M
    Nephrol Dial Transplant; 2002; 17 Suppl 2():30-4. PubMed ID: 11904356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoride and strontium accumulation in bone does not correlate with osteoid tissue in dialysis patients.
    Cohen-Solal ME; Augry F; Mauras Y; Morieux C; Allain P; de Vernejoul MC
    Nephrol Dial Transplant; 2002 Mar; 17(3):449-54. PubMed ID: 11865091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased bone strontium levels in hemodialysis patients with osteomalacia.
    D'Haese PC; Schrooten I; Goodman WG; Cabrera WE; Lamberts LV; Elseviers MM; Couttenye MM; De Broe ME
    Kidney Int; 2000 Mar; 57(3):1107-14. PubMed ID: 10720963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of trace elements in uraemic toxicity.
    Vanholder R; Cornelis R; Dhondt A; Lameire N
    Nephrol Dial Transplant; 2002; 17 Suppl 2():2-8. PubMed ID: 11904350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adequacy of dialysis: trace elements in dialysis fluids.
    D'Haese PC; De Broe ME
    Nephrol Dial Transplant; 1996; 11 Suppl 2():92-7. PubMed ID: 8804004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent effects of strontium on bone of chronic renal failure rats.
    Schrooten I; Behets GJ; Cabrera WE; Vercauteren SR; Lamberts LV; Verberckmoes SC; Bervoets AJ; Dams G; Goodman WG; De Broe ME; D'Haese PC
    Kidney Int; 2003 Mar; 63(3):927-35. PubMed ID: 12631073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low bone turnover in patients with renal failure.
    Couttenye MM; D'Haese PC; Verschoren WJ; Behets GJ; Schrooten I; De Broe ME
    Kidney Int Suppl; 1999 Dec; 73():S70-6. PubMed ID: 10633468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strontium causes osteomalacia in chronic renal failure rats.
    Schrooten I; Cabrera W; Goodman WG; Dauwe S; Lamberts LV; Marynissen R; Dorriné W; De Broe ME; D'Haese PC
    Kidney Int; 1998 Aug; 54(2):448-56. PubMed ID: 9690211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-evolution and reversibility of strontium-induced osteomalacia in chronic renal failure rats.
    Oste L; Bervoets AR; Behets GJ; Dams G; Marijnissen RL; Geryl H; Lamberts LV; Verberckmoes SC; Van Hoof VO; De Broe ME; D'Haese PC
    Kidney Int; 2005 Mar; 67(3):920-30. PubMed ID: 15698431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis.
    Spasovski GB; Bervoets AR; Behets GJ; Ivanovski N; Sikole A; Dams G; Couttenye MM; De Broe ME; D'Haese PC
    Nephrol Dial Transplant; 2003 Jun; 18(6):1159-66. PubMed ID: 12748350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum strontium levels in dialysis patients: an epidemiological survey.
    Schrooten I; Elseviers MM; Lamberts LV; De Broe ME; D'Haese PC
    Kidney Int; 1999 Nov; 56(5):1886-92. PubMed ID: 10571798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cadmium overload and toxicity.
    Järup L
    Nephrol Dial Transplant; 2002; 17 Suppl 2():35-9. PubMed ID: 11904357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminium and bone disease in chronic renal failure.
    Malluche HH
    Nephrol Dial Transplant; 2002; 17 Suppl 2():21-4. PubMed ID: 11904354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal osteodystrophy in developing countries.
    Afifi A
    Artif Organs; 2002 Sep; 26(9):767-9. PubMed ID: 12197931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
    Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overload.
    D'Haese PC; Couttenye MM; Goodman WG; Lemoniatou E; Digenis P; Sotornik I; Fagalde A; Barsoum RS; Lamberts LV; De Broe ME
    Nephrol Dial Transplant; 1995 Oct; 10(10):1874-84. PubMed ID: 8592597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
    Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of strontium on bone metabolism in hemodialysis patients].
    Gerstenfeld S; Hinojosa L; Serrano Arias M; Menéndez Rodríguez P; Fernández Martín JL; Marchante JM; García Alonso JI; Sanz-Medel A; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():52-6. PubMed ID: 12778855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between chronic, toxic bone damage and foreign metal binding to serum proteins].
    Schmid A; Gutschow K
    Arch Toxikol; 1968; 23(3):245-9. PubMed ID: 5704795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.